Nordic Capital acquired a majority stake in health data platform Arcadia. Together, the two aim to accelerate the company’s mission of advancing value-based care through AI and data analytics. Arcadia CEO Michael Meucci views the deal as both a validation of the company’s strategy and part of a broader wave of healthcare investments focused on…
In his latest column for the JAMA Health Forum, KFF’s Larry Levitt talks about how popular shows like “The Pitt” can make changes to the health care system stemming from this year’s federal tax and budget bill tangible for viewers, and offers some suggested story lines.
When patients disengage, preventive care is missed, chronic conditions worsen, care shifts to higher-cost settings such as the emergency department and urgent care, and patients fragment across systems, reducing continuity. The post Stopping Patient Attrition Before it Starts: A Proactive Approach to Healthcare Marketing appeared first on MedCity News.
As hospitals face ongoing cost pressures and supply chain disruptions, Allina Health is redesigning its procurement strategy by moving away from a decentralized sourcing model and toward an approach that prioritizes governance and tech-driven efficiencies. Chief Supply Chain Officer Tom Lubotsky shared how the health system is saving money and boosting supply chain resilience. The…
Solera has created framework for responsible and transparent use of AI in digital health for use across its partner ecosystem
Neko’s Series C round was co-led by Lightspeed Venture Partners and O.G. Venture Partners, with participation from Atomico, General Catalyst, Lakestar, Liberty City Ventures, Positive Sum and BDT & MSD. The post Neko Health Secures $700M to Support US Expansion appeared first on MedCity News.
Fact sheet examining actions taken by the Trump administration and their impact on the Global Fund to Fight AIDS, Tuberculosis and Malaria.
Amid political and medical disagreements, the report emphasizes potential health risks
The structure of Atalanta Therapeutics’ RNA interference drugs enables them to distribute broadly and deeply into brain tissue. Lead programs for Huntington’s disease and a rare inherited form epilepsy are on track to enter the clinic this year. The post RNAi Biotech Atalanta Unveils $97M to Reach the Clinic in Two Rare Neuro Diseases appeared…
Reperio Health is trying to really boost the delivery of at home health testing, including not only weight and blood pressure but also cholesterol, obesity and blood sugar. Having use the kit and done an at home demo, I’m pretty interested to see if this can be a front-end telehealth service to get the average…